Namenda Xr
NDC Package 68151-5829-8

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Namenda Xr is memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. Marketed by Carilion Materials Management, this product is identified by NDC 68151-5829 and is authorized under FDA application NDA022525.

Identification & Billing

NDC Package Code
68151-5829-8
Package Description
1 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code
68151-5829
11-Digit Billing Format
68151582908
RxNorm Crosswalk
  • RxCUI: 996594 - memantine HCl 14 MG 24HR Extended Release Oral Capsule
  • RxCUI: 996594 - 24 HR memantine hydrochloride 14 MG Extended Release Oral Capsule
  • RxCUI: 996594 - memantine hydrochloride 14 MG 24 HR Extended Release Oral Capsule
  • RxCUI: 996597 - Namenda XR 14 MG 24HR Extended Release Oral Capsule
  • RxCUI: 996597 - 24 HR memantine hydrochloride 14 MG Extended Release Oral Capsule [Namenda]

Clinical Specifications

Proprietary Name
Namenda Xr
Dosage Form
-
Usage Information
Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

Regulatory & Marketing

Labeler Name
Carilion Materials Management
FDA Application #
NDA022525
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-31-2011
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68151-5829-8 identifies a specific commercial package of 1 capsule, extended release in 1 bottle of Namenda Xr, labeled by Carilion Materials Management. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Carilion Materials Management on October 31, 2011. The current certification is valid through December 31, 2018.

What are the primary indications for this medication?

Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

How is this Carilion Materials Management product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68151582908. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68151-5829-8
11-Digit CMS (5-4-2)
68151-5829-08

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.